COMMITMENTS AND CONTINGENCIES - Securities Litigation (Narrative) (Details) $ in Millions, ₪ in Billions				1 Months Ended			3 Months Ended	12 Months Ended
	Apr. 05, 2024 USD ($)	Jun. 28, 2017 USD ($) individual $ / ₪	Jun. 28, 2017 ILS (₪) individual $ / ₪	Jan. 31, 2025 plaintiff	May 31, 2024 USD ($)	Jun. 30, 2020 plaintiff	Mar. 30, 2024 USD ($)	Dec. 31, 2024 USD ($) claim	Nov. 14, 2019 class	Jun. 21, 2017 individual product
Loss Contingencies [Line Items]
Number of current or former directors and officers | individual										11
Number of generic prescription pharmaceuticals | product										6
Securities Litigation in the United States
Loss Contingencies [Line Items]
Number of generic prescription pharmaceuticals | product										6
Number of putative classes | class									3
Preliminary class damages	$ 97.0
Loss provision							$ 34.0	$ 96.0
Damages paid					$ 97.0
Number of cases dismissed | claim								13
Number of plaintiffs | plaintiff						3
Securities Litigation in the United States | Subsequent Event
Loss Contingencies [Line Items]
Number of plaintiffs | plaintiff				3
Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al.
Loss Contingencies [Line Items]
Number of current or former directors and officers | individual		11	11
Preliminary class damages		$ 760.0	₪ 2.7
Foreign currency exchange rate, remeasurement | $ / ₪		0.28	0.28